Kymera Therapeutics, Inc. financial data

Symbol
KYMR on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 872% % 2.9%
Debt-to-equity 14% % -24%
Return On Equity -29% % -1.5%
Return On Assets -25% % -5.3%
Operating Margin -891% % -60%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 81,642,394 shares 25%
Common Stock, Shares, Outstanding 81,323,532 shares 25%
Entity Public Float $2,294,800,000 USD
Common Stock, Value, Issued $8,000 USD 14%
Weighted Average Number of Shares Outstanding, Basic 84,490,585 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 84,490,585 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $39,211,000 USD -17%
Cost of Revenue $39,211,000 USD -17%
Research and Development Expense $316,568,000 USD 32%
General and Administrative Expense $68,187,000 USD 7.3%
Operating Income (Loss) $349,399,000 USD -34%
Net Income (Loss) Attributable to Parent $311,351,000 USD -39%
Earnings Per Share, Basic -3.69 USD/shares -24%
Earnings Per Share, Diluted -3.69 USD/shares -24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $357,011,000 USD 197%
Accounts Receivable, after Allowance for Credit Loss, Current $40,000,000 USD
Assets, Current $871,214,000 USD 71%
Property, Plant and Equipment, Net $43,175,000 USD -14%
Operating Lease, Right-of-Use Asset $42,351,000 USD -11%
Other Assets, Noncurrent $9,114,000 USD 367%
Assets $1,742,812,000 USD 78%
Accounts Payable, Current $4,015,000 USD -33%
Accrued Liabilities, Current $42,274,000 USD 21%
Contract with Customer, Liability, Current $22,925,000 USD 69%
Liabilities, Current $83,212,000 USD 23%
Contract with Customer, Liability, Noncurrent $11,440,000 USD
Operating Lease, Liability, Noncurrent $67,034,000 USD -7.4%
Other Liabilities, Noncurrent $0 USD
Liabilities $163,148,000 USD 15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,800,000 USD
Retained Earnings (Accumulated Deficit) $1,065,961,000 USD -41%
Stockholders' Equity Attributable to Parent $1,579,664,000 USD 89%
Liabilities and Equity $1,742,812,000 USD 78%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $79,150,000 USD -100%
Net Cash Provided by (Used in) Financing Activities $258,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $48,615,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 81,323,532 shares 25%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $30,277,000 USD -84%
Interest Paid, Excluding Capitalized Interest, Operating Activities $77,000 USD 57%
Deferred Tax Assets, Valuation Allowance $330,285,000 USD 40%
Deferred Tax Assets, Gross $351,393,000 USD 35%
Operating Lease, Liability $78,975,000 USD -6%
Depreciation $8,300,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $467,000 USD -94%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $308,066,000 USD -37%
Lessee, Operating Lease, Liability, to be Paid $112,862,000 USD -9.7%
Property, Plant and Equipment, Gross $65,302,000 USD -1.8%
Operating Lease, Liability, Current $11,941,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $12,809,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,436,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.087 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33,887,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three $13,193,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $159,311,000 USD 159%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $13,589,000 USD 3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,048,000 USD 40%
Deferred Tax Assets, Net of Valuation Allowance $21,108,000 USD -10%
Share-based Payment Arrangement, Expense $59,904,000 USD 8.9%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%